Cargando…
Emerging role of m6A methylation modification in ovarian cancer
m6A (N6-methyladenosine) methylation, a well-known modification in tumour epigenetics, dynamically and reversibly fine tunes the entire process of RNA metabolism. Aberrant levels of m6A and its regulators, which can predict the survival and outcomes of cancer patients, are involved in tumorigenesis,...
Autores principales: | Chang, Lin-Lin, Xu, Xia-Qing, Liu, Xue-Ling, Guo, Qian-Qian, Fan, Yan-Nan, He, Bao-Xia, Zhang, Wen-Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666073/ https://www.ncbi.nlm.nih.gov/pubmed/34895230 http://dx.doi.org/10.1186/s12935-021-02371-3 |
Ejemplares similares
-
m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia
por: Xu, Zi-Jun, et al.
Publicado: (2022) -
m6A Regulator-Mediated Methylation Modification Patterns and Characteristics in COVID-19 Patients
por: Qing, Xin, et al.
Publicado: (2022) -
The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer
por: Zhu, Wenjing, et al.
Publicado: (2022) -
Characterization of the m(6)A regulator-mediated methylation modification patterns in oral squamous cell carcinoma
por: Pan, Lu, et al.
Publicado: (2023) -
WTAP affects intracranial aneurysm progression by regulating m6A methylation modification
por: Yuan, Xuesong, et al.
Publicado: (2023)